Key result
Biomarkers enhance detection, treatment, and overall management of non-communicable diseases.
Answers are grounded in this paper and cite their sources.
Laboratory medicine and specific biomarkers are essential for understanding disease pathology and managing non-communicable diseases.
Non-communicable diseases (NCDs) are chronic, non-transmissible medical conditions. They are broadly categorized into the four main types of NCDs: chronic respiratory diseases, cardiovascular diseases, cancer and diabetes but include also other common NCDs such as neurological and mental health disorders or chronic kidney diseases. They account for over 80 % of the disease burden in EU countries and are the leading causes of premature death. Risk factors for NCDs include behavioral factors such as unhealthy diets, tobacco or alcohol use, metabolic risk factors such as obesity, abnormal blood lipids or raised blood pressure as well as environmental factors including contact with air pollen and pollution or other harmful agents. Clinical management of NCDs consists of detecting, screening and treating these diseases. The search for and identification of specific biomarkers is a major milestone in understanding disease pathology and should assist the detection, treatment and management of multiple NCDs. Thereby, a close cooperation between laboratory medicine and other clinical departments is important. Here we review our recent contributions in laboratory diagnostic and biomarker research in the management of NCDs in national and international collaborations.
No takes yet. Share an insight, caveat, or question.
Nockher et al. (2026) conducted a review in Non-communicable diseases. Biomarkers and laboratory medicine was evaluated. Biomarkers and laboratory medicine play a crucial role in understanding disease pathology and assisting the detection, treatment, and management of non-communicable diseases.
Synapse has enriched 10 related papers. Consider them for comparative context: